The American Society of Clinical Oncology and the American Urological Association issued guidelines suggesting that the drug finasteride could reduce by as much as 25% the risk of prostate cancer in middle-age men who undergo regular screening. The drug, which is used to treat urinary problems and male pattern baldness, has been found to shrink the prostate and lower testosterone, which can contribute to cancer growth.

Related Summaries